Abstract
Aims
In infective endocarditis (IE), a severe inflammatory disease of the endocardium with an unchanged incidence and mortality rate over the past decades, only 1% of the cases have been described as polymicrobial infections based on microbiological approaches. The aim of this study was to identify potential biodiversity of bacterial species from infected native and prosthetic valves. Furthermore, we compared the ultrastructural micro-environments to detect the localization and distribution patterns of pathogens in IE.
Material and methods
Using next-generation sequencing (NGS) of 16S rDNA, which allows analysis of the entire bacterial community within a single sample, we investigated the biodiversity of infectious bacterial species from resected native and prosthetic valves in a clinical cohort of 8 IE patients. Furthermore, we investigated the ultrastructural infected valve micro-environment by focused ion beam scanning electron microscopy (FIB-SEM).
Results
Biodiversity was detected in 7 of 8 resected heart valves. This comprised 13 bacterial genera and 16 species. In addition to 11 pathogens already described as being IE related, 5 bacterial species were identified as having a novel association. In contrast, valve and blood culture-based diagnosis revealed only 4 species from 3 bacterial genera and did not show any relevant antibiotic resistance. The antibiotics chosen on this basis for treatment, however, did not cover the bacterial spectra identified by our amplicon sequencing analysis in 4 of 8 cases. In addition to intramural distribution patterns of infective bacteria, intracellular localization with evidence of bacterial immune escape mechanisms was identified.
Conclusion
The high frequency of polymicrobial infections, pathogen diversity, and intracellular persistence of common IE-causing bacteria may provide clues to help explain the persistent and devastating mortality rate observed for IE. Improved bacterial diagnosis by 16S rDNA NGS that increases the ability to tailor antibiotic therapy may result in improved outcomes.
Introduction
Infective endocarditis (IE) of native and prosthetic heart valves is a severe inflammatory disease of the endocardium, affecting valve structure and function and leading to death if left untreated [1–8]. Identifying the causative microorganism(s) is crucial for patient survival, lowering the risk of recurrent prosthetic valve infection, and tailoring the type and duration of antibiosis [9, 10]. Blood and valve analyses are culture-based methods and thereby restricted to those bacteria able to proliferate. It is still unclear whether bacteria cultured from blood represent the authentic pathogenic spectra of infected valves.
There are significant challenges in detecting the culprit microbe responsible for IE. Culture-based methods have limited sensitivity, especially when antibiotic therapy has already been initiated or when fastidious or slowly growing microorganisms are involved [11]. In fact, country-specific clinical studies revealed that blood culture failed to detect a species in 10–48% of patients [6, 12, 13].
The origin of pathogens responsible for IE is primarily thought to stem from systemic bacteremia as a result of lesions or surgical interventions of skin or mucosa, leading to barrier leakage and bacterial invasion. If so, one would expect that bacterial diversity would result in polymicrobial infections. Interestingly, however, polymicrobial infections have been described in only 1% of cases [6]. This is clinically significant as polymicrobial infections have been shown to reduce the rate of cure in other infectious diseases [14].
The goal of this study was to identify the pathogen spectra of infected valves using next-generation sequencing (NGS)-based 16S rDNA analysis. We aimed to:
identify the potential biodiversity of infectious bacterial species from native and prosthetic valves of IE patients in a clinical cohort of 8 patients;
analyze and compare infected native and prosthetic valve ultrastructural micro-environments by high-resolution focused ion beam scanning electron microscopy (FIB-SEM) to detect the localization and distribution patterns of pathogens.
Material and methods
Phenotype characteristics
The study was approved by the ethics committee of the University of Leipzig, and participants provide their written informed consent to participate in this study (286/13ff, November 2013). In our study we included 8 patients (6 men and 2 women; mean age 71.4 years; range 63–87 years, Table 1). All patients were diagnosed with IE according to the modified Duke criteria (15) as presented in Table 2. They underwent surgery for acute IE at the Heart Center Leipzig (Germany). The seven patients were randomly selected out of 57 patients by using the SPSS statistics software package. Explanted heart valves of all patients selected for our study were additionally analyzed by histological methods and diagnosed as an acute IE by expert pathologists.
Table 1. Phenotype.
Valve patients | |
---|---|
n [male] | 8 [6] |
Age [Years] | 71.4 ± 9.04 |
Height [cm] | 170.63 ± 8.55 |
Weight [kg] | 90.6 ± 25.73 |
BMI [kg/m2] | 30.71 ± 6.4 |
BSA [m2] | 2.06 ± 0.3 |
LVEF [%] | 54.38 ± 12.77 |
EuroScore [log] | 46.37 ± 29.13 |
EuroScore | 13.00 ± 4.96 |
Comorbidities | |
Hypertension [n] | 6 |
CAD [n] | 3 |
DMT2 [n] | 2 |
Valve regurgitation [n] | 8 |
Blood parameter | |
Creatine [μmol] | 146.45 ± 154.45 |
Uric acid [mmol/l] | 9.68 ± 7.27 |
ASAT [μmol/l*s] | 0.60 ± 0.18 |
GGT [μmol/l*s] | 2.01 ± 20.55 |
Lipase [U/l] | 31.86 ± 20.55 |
Cholesterase [μmol/l*s] | 50.69 ± 29.61 |
Leucocytes [Gpt/l] | 12.72 ±6.12 |
CrP [mg/l] | 102.92 ± 82,83 |
Values shown are n or mean ± SD. Abbreviations: n = number; BMI—body-mass-index; BSA—body surface area; LVEF—left ventricular ejection fraction; EuroScore—European system for cardiac operative risk evaluation; CAD—coronary artery disease; DMT2—diabetes mellitus type 2; ASAT—aspartate aminotransferase; GGT—gamma-glutamyl transpeptidase; CrP—C-reactive protein.
Table 2. Clinical characteristics.
Patient no. | Native valve | Biological prosthesis | ||||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
Valve type | TV | MV | AV | MV | AV | AV | AV | AV |
Duke Criteria | ||||||||
Major | Echo positive, BC positive |
Echo positive, BC positive |
Echo positive, BC positive |
Echo positive, BC negative |
Echo positive, BC positive |
Echo positive, BC positive |
Echo positive, BC positive |
Echo positive, BC positive |
Minor | fever, PM-Lead in RV, leg ischemia |
fever, immune- suppressed |
fever | fever, prosthesis, TIA |
fever, prosthesis, cranial septic embolism |
fever, prosthesis |
fever, prosthesis |
fever, prosthesis |
Standard microbiology analysis | ||||||||
Blood culture | Staph. aureus | Enterococ. faecalis | Strep. gordonii | Ø | Staph. aureus | Staph. epidermidis | Staph. aureus | Enterococ. faecalis |
Valve swab | Ø | Ø | Ø | Ø | Staph. aureus | Ø | Ø | Ø |
Valve ultra-sound | Ø | Staph. epidermidis | Strep. gordonii | Ø | Staph. aureus | Ø | Ø | Enterococ. faecalis |
Antibiotic therapy | ||||||||
Initial | Flucloxacillin Rifampicin |
Tazobactam | Ø | Ampicillin/ Sulbactam Rifampicin |
Vancomycin Cefuroxime |
Tazobactam | Vancomycin Gentamycin Rifampicin |
Ampicillin Imipenem |
Extended | Cefazolin Rifampicin |
Gentamycin Vancomycin Imipenem |
Gentamycin Vancomycin Imipenem |
Ampicillin/ Sulbactam Rifampicin |
Vancomycin Cefuroxime |
Vancomycin Gentamycin |
Vancomycin Gentamycin Rifampicin |
Vancomycin Gentamycin Rifampicin |
Mortality (postoperative within 30 days) | ||||||||
Survival | Yes | Yes | Yes | death | Yes | death | Yes | Yes |
Histological findings | ||||||||
Structural |
Staph. aureus, intramural, correlated to nuclear structures |
- |
Staph. aureus, intramural, correlated to nuclear structures |
- |
Staph. aureus, intramural, correlated to nuclear structures |
Staph. aureus, intramural, correlated to nuclear structures |
Staph. aureus, intramural, correlated to nuclear structures |
Staph. aureus, intramural, correlated to nuclear structures |
Ultra-Structural | - | - | bacteria, intracellular and intramural, smooth surface structure |
- | bacteria, intracellular and intramural |
- | bacteria, rough surface structure |
- |
Abbreviations: TV—tricuspid valve; MV—mitral valve; AV—aortic valve; BC—blood culture; PM–peacemaker; RV—right ventricular; TIA—transient ischemic attack; Ø—negative; Staph.—Staphylococcus; Enterococ.–Enterococcus; Strep.–Streptococcus.
Microbiological analysis
Clinical specimens from heart valve tissue were placed into sterile tubes filled with 6 ml of brain-heart-infusion broth (BHI) supplemented with 5% Fildes extract (both OXOID Ltd., Hampshire, England) and placed into an ultrasonic bath (BactoSonic®, BANDELIN electronic GmbH & Co. KG, Berlin, Germany). Sonication was performed for 15 min at an ultrasound frequency of 35 kHz to expose bacteria located in biofilms on the valve surface and to convert them into a planktonic state. Subsequently, the samples were incubated in a CO2-enriched atmosphere (5%) at a temperature of 37°C for 14 days. Turbidity, as evidence of bacterial growth, was assessed at days 4, 7, and 14 of incubation. The samples with suspected growth were inoculated onto 5% sheep blood-containing Columbia agar (Roth), Columbia agar supplemented with cooked blood and IsoVitalex (BD BBL, Le Pont de Claix, France), Endo-agar (Fluka, Sigma-Aldrich Chemie GmbH, Steinheim, Germany), Aesculine-agar (OXOID), and Sabouraud-2%-glucose agar plates (Sifin diagnostics GmbH, Berlin, Germany) as well as onto anaerobic media (supplemented Brucella agar (BD BBL) and incubated for a duration of 4 days under a capnophilic (5% CO2) and anaerobic atmosphere (GenBag, BioMérieux, Marcy LÈtoile, France) at 37°C. Blood agar plates were cross-streaked with Staphylococcus aureus H1 to enable growth of nutritionally fastidious bacteria showing satellite phenomena. Growth was evaluated daily. After 14 days of incubation, all samples were subcultured independently of whether they showed evidence of prior growth or not. If a subculture showed bacterial growth, identification was established by VITEK® MALDI-ToF MS (BioMérieux Inc., Durham, NC, USA), and antimicrobial susceptibility testing was performed via the broth microdilution method or Epsilometer tests (Etest AB Biodisk, Solna, Sweden) according to the EUCAST guidelines. For long-term storage, a microbial cryopreservation stock with Cryobank™ (Mast Diagnostica GmbH, Reinfeld, Germany) was created for each strain.
An average of two sets of blood samples were collected during the operative setting from the heart-lung machine (HLM), central venous catheter, or by peripheral venous puncture. Samples of approximately 10 ml of blood thus collected were inoculated into aerobic and anaerobic blood culture bottles (BacT/ALERT FA/FN, BioMérieux Inc., Durham, NC, USA) and kept at room temperature. In the laboratory, blood culture bottles were placed into an automated continuous monitoring system (BacT/ALERT 3D) and incubated at 36°C for a prolonged period of 21 days. When algorithms indicated bacterial growth in a bottle, subculture was performed on the solid media as described above. Subcultures were incubated again for 4 days under a capnophilic and anaerobic atmosphere at a temperature of 36°C. Identification and antimicrobial susceptibility testing were performed as described above. In cases where bacterial growth did not occur on solid media, blood culture bottles were further incubated at 37°C and manual subculture was repeated twice during the 21 days of incubation.
Analysis of the metagenome
To identify the bacterial spectra of infected native and prosthetic heart valves using culture-independent, genome-based analyses, total DNA was extracted from clinical specimens. Two different regions of bacterial 16S rDNA (V1-V3 and V3-V4) were amplified and analyzed using NGS to yield a maximal identifiable number of species. To test whether the discovery rate might be improved by a bacterial DNA enrichment procedure, a fraction of isolated total DNA was pretreated using the NEB Next Microbiome DNA Enrichment kit (New England BioLabs, Frankfurt am Main, Germany) prior to PCR amplification and amplicon sequencing. To determine the discovery rates of metagenome experiments, 8 randomly selected samples were subjected to repeated analysis (S3 Fig).
DNA extraction and 16S rDNA amplification
Heart valve tissue (25 mg) was homogenized in phosphate-buffered saline, and total DNA was extracted with the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Microbial DNA was enriched by using the NEBNext@ Microbiome DNA Enrichment kit. Subsequently, two hypervariable regions of bacterial 16S rRNA gene were amplified using well-established primers [15]. The following primer pairs for polymerase chain reaction (PCR) amplification were used: for the V1-V3 hypervariable region: 27F (5`-AGAGTTTGATCCTGGCTCAG-3`) and 534R (5`-ATTACCGCGGCTGCTGG-3`); for the V3-V5 hypervariable region: 357F (5`-CCTACGGGAGGCAGCAG-3`) and 926R (5`-CCGTCAATTCMTTTRAGT-3`). Briefly, each 20 μL of PCR reaction mixture contained 20 ng of total or microbial-enriched DNA as a template, 10 μL 2x Hot Start Taq Master Mix (New England BioLabs), and 0.5 μM of each primer. PCR reactions were carried out using the following protocols: (1) for the V1-V3 hypervariable region, an initial denaturation step performed at 95°C for 30 s followed by 30 cycles of denaturation (95°C, 30 s), annealing (56°C, 40 s), and extension (68°C, 1 min), and a final elongation of 5 min at 68°C; (2) for the V3-V5 hypervariable region, the parameters were the same as above except that the annealing temperature was 59°C. PCR products were visualized by agarose gel electrophoresis, showing expected product sizes (500 and 550 bp for the V1-V3 and V3-V5 regions, respectively) in all samples. Water was used as negative control in the PCR reaction. PCR products were purified using QIAquick PCR Purification Kit (Qiagen) and quantified using a NanoDrop 1000 Spectrophotometer (VWR International GmbH, Erlangen, Germany) or a Qubit 3.0 Fluorometer (Life Technologies, Darmstadt, Germany). As key control experiments, DNA was also extracted from water to ensure absence of contaminating bacterial DNA in water, buffer, equipment, and reagents. Furthermore, DNA was also extracted from valve tissue of non-infected patients (S2 Fig).
Library preparation and next-generation sequencing
Illumina paired-end sequencing libraries were constructed from purified PCR fragments using the NEBNext® DNA Library Prep Master Mix Set and Multiplex Oligos for Illumina (New England BioLabs) following standard sample preparation. One μg of purified PCR products was end-repaired, dA-tailed, ligated to platform-specific adaptors, size-selected to an average size of 500–550 bp by Agencourt AMPure XP beads (Beckman Coulter), and amplified by 4 to 8 cycles of PCR. Finally, multiplexed paired-end sequencing (2×300 bp reads) of the 16S rDNA amplicons was performed using Illumina MiSeq technology (MiSeq Reagent Kit v3 600 cycles, Illumina).
Sequence analysis and bioinformatics
Quality of reads was controlled using fastqc (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Adapters and low-quality bases were trimmed using Trimmomatic [16]; very short reads were removed. Remaining reads were aligned to the NCBI database 16SMicrobial using software blast in megablast mode [17], requiring a maximum e value of 0.001. Local alignment was repeated with minimum identity filters of 95%, 97%, and 99%. Blast results were then analyzed with MEGAN5 [18] in paired-end mode, requiring a minimum bit score of 60, using the NCBI taxonomy. Taxonomic classification was summarized at the species level and further analyzed using statistics software R (http://www.R-project.org/). For comparison of different samples, species and genus results were standardized as a proportion of all aligned reads. Cut-off levels of at least 0.1%, 0.5%, 1%, 2%, and 10% of species/genus-specific reads were applied (S3 Fig).
Quantitative PCR (qPCR)
DNA of bacterial cultures Haloplasma contractile (DSM 18853), Burkholderia fungorum (DSM 17061), and Aeribacillus pallidus (DSM 3670) were obtained from the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany).
Staphylococcus aureus, Enterococcus faecalis, and Streptococcus gordonii were isolated from heart valve tissue and cultured as described above. After cell lysis with 20 mg/ml lysozyme (20 mM Tris·HCl, pH 8.0; 2 mM EDTA; 1.2% Triton) the bacterial DNA was extracted with the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Purified DNA from monocultures was used as positive control templates in qPCR. The concentration of specific DNA dilutions was plotted against the Cp (crossing point) value to generate a standard curve used for absolute quantification.
The primers listed in Table 3 were synthesized by Eurofins Genomics (Ebersberg, Germany). PCR amplification was performed using a Roche Light Cycler 480 (Roche Diagnostics, Mannheim, Germany) with the SYBR Green fluorescence dye (QuantiNova SYBR Green PCR Kit, Qiagen, Hilden, Germany). The reaction was performed in a total volume of 20 μl. The PCR protocol consisted of an initial denaturation at 95°C for 2 min; 40 cycles of denaturation for 5 s at 95°C, and combined annealing/extension 10 s at 60°C. The serial dilution standards, negative controls, and samples were measured simultaneously in duplicate. At the end of amplification, SYBR green fluorescence was measured continuously during the melting curve by heating at 2.2°C/s increments from 65 to 95°C with continuous fluorescence monitoring. Accordingly, a melting curve was generated at the end of the PCR amplification as a measure of the specificity of the PCR reaction.
Table 3. Species-specific qPCR primers.
Species | Primer | Sequence (5‘-3‘) | PCR product (bp) | Reference |
---|---|---|---|---|
Staphylococcus aureus | Sa442-1 | AAT CTT TGT CGG TAC ACG ATA TTC TTC ACG | 108 | [19] |
Sa442-2 | CGT AAT GAG ATT TCA GTA GAT AAT ACA ACA | |||
Enterococcus faecalis | FL1_F | ACT TAT GTG ACT AAC TTA ACC | 360 | [20] |
FL2_R | TAA TGG TGA ATC TTG GTT TGG | |||
Streptococcus gordonii | Sgo_F2 | TGT ACC CCG TAT CGT TCC TGT G | 175 | [21] |
Sgo_R2 | AAA GAC TGG AGT TGC AAT GTG AAT A | |||
Burkholderia fungorum | FunF | GTC ATG CGG CTC GGC GCA GGT | 324 | [22] |
FunR | GAG TGC GTC GGC AAT CTC GAG T | |||
Haloplasma contractile | Hc_F | CGT TGA GTG CTA AGT GTC GG | 185 | [23] |
Hc_R | GTC AGA GGG ATG TCA AGG CT | |||
Aeribacillus pallidus | Ap_F | TCC CCT GAC AAC CCT AGA GA | 174 | [23] |
Ap_R | TTT AGC CGG CAG TCA CCT TA |
Histological staining
Cryosections of heart valve tissue were fixed with 4% paraformaldehyde and incubated overnight at 4°C with anti-Staphylococcus aureus antibody (1:100; anti-Staphylococcus aureus antibody 704, ab37644, abcam, Germany). Indirect immunofluorescence was performed using secondary antibodies conjugated with Alexa Fluor 488 (1:500; Invitrogen, Life Technologies GmbH). Cell nuclei were stained with hexidium iodide (1:500; Molecular Probes, Life Technologies GmbH, Darmstadt, Germany). The tissues were analyzed with a Zeiss LSM-5 Pascal confocal laser scanning microscope (Carl Zeiss, Jena, Germany).
Scanning electron microscopy
The heart valve tissues were cut into pieces of 2 mm3 and fixed with 2.5% glutaraldehyde and 2% paraformaldehyde in 0.15 M cacodylate buffer (pH 7.4) containing 2 mM calcium chloride at 35°C for 5 min. Target tissues were removed and fixed for an additional 2–3 h on ice in the same solution. They were washed 5 x 3 min in cold cacodylate buffer containing 2 mM calcium chloride. Immediately prior to use, a solution containing 3% potassium ferrocyanide in 0.3 M cacodylate buffer with 4 mM calcium chloride was combined with an equal volume of 4% aqueous osmium tetroxide. The tissues were incubated in this solution for 1 h on ice. Tissues were then washed 5 x 3 min with doubly distilled water (ddH2O) at room temperature and placed in filtered thiocarbohydrazide solution for 20 min at room temperature. Another washing cycle (5 x 3 min) with ddH2O at room temperature followed. Thereafter, tissues were placed in 2% osmium tetroxide in ddH20 for 30 min at room temperature. Following this second exposure to osmium, tissues were washed 5 x 3 min at room temperature in ddH2O, placed in 1% uranyl acetate (aqueous), and left in a refrigerator (~4°C) overnight. The next day, en bloc Walton’s lead aspartate staining was performed. Thus, tissues were washed 5 x 3 min in ddH2O at room temperature and then placed in the lead aspartate solution for 30 min at 60°C. After another washing cycle (5 x 3 min at room temperature in ddH2O), tissues were dehydrated using ice-cold solutions of freshly prepared 20%, 50%, 70%, 90%, 100%, and 100% ethanol (anhydrous) for 5 min each, placed in hexamethyldisilazane for 10 min, and dried at room temperature. Specimens were mounted on standard scanning electron microscopy (SEM) stubs with carbon tape (PELCO® Isopropanol Based Graphite Paint) and stored overnight at 30°C. The cured samples were finally sputter-coated (Leica EM ACE200) with a 5–10 nm thick platinum layer and evaluated with a scanning electron microscope (Zeiss Sigma VP).
For 3View-SEM and FIB-SEM, small pieces of heart valve tissues were fixed in 2% glutaraldehyde in 0.1 M cacodylate buffer (pH7.4). Heavy metal contrast enhancement was performed according to the protocol of Deerinck et al. [24]. Specimens were embedded in especially hard epoxy resins Durcupan™ ACM or Araldite® 506 (Sigma Aldrich, Steinheim, Germany). Micro air bubbles were removed by vacuum during resin penetration and hardening. We used a Crossbeam® Auriga 60 (Zeiss) with gallium ion beam and combined SE-/ EsB-Imaging for optimal contrast. Stacks of several hundred images were automatically acquired with maximum resolution of 2.5 nm x 12.5 nm x 5 nm (xyz). For 3D reconstruction analysis we used Amira® 5.0 3D Image Analysis software package (vsg, Düsseldorf, Germany) on a Mac Pro workstation (Apple Inc., Cupertino, CA, USA).
A summary of the complete workflow is depicted in S3 Fig.
Results
Clinical characteristics
Among the 8 cases of definitive endocarditis (Table 1), blood cultures were positive in 7 and microbiological analysis of valve tissue revealed positive results in 4 patients (Table 2). After surgery, histopathological criteria of IE were present in all definitive cases (data not shown). Blood culture analysis revealed Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus gordonii and Enterococcus faecalis in 3, 1, 1 and 2 cases, respectively (Table 2).
To improve the identification of valve-related bacterial infection, we extended our protocol by utilizing a novel, ultrasound-based pretreatment procedure of the valve to extract bacteria from the tissue. The analysis of a valve swab revealed only 12.5% sensitivity (one pathogen in patient 5, Staphylococcus aureus) whereas ultrasound pretreatment increased the number of identified pathogens and raised the sensitivity to 50% (Table 2). The discrepancy in the results of valve swab analysis and the ultrasound-based pretreatment procedure indicates that pathogen localization may be responsible for the low sensitivity observed by microbiological standard diagnostics. Therefore, we performed FIB-SEM-based ultrastructural analysis to visualize localization of infective bacteria.
Structural analysis using confocal fluorescence microscopy
Histological staining for Staphylococcus aureus in infected native (2 patients) and biological prosthetic (4 patients) valve tissues revealed its presence in all samples analyzed. (S1 Fig, Table 2) Bacteria seem to be localized intramurally as well as in proximity to eukaryotic nuclear structures (S1 Fig, Table 2).
Ultrastructural analysis using electron microscopy
To obtain data that may provide an explanation for the low sensitivity of microbial valve culture diagnosis, we applied sophisticated electron microscopy (FIB-SEM) to one infected native and two biological prosthetic valve specimens (Fig 1A–1D). First, ultrastructural analysis revealed a smooth surface with frequently discernable epithelial cell boundaries in the native valve (Fig 1B) and a rather rough-structured surface characterized by deep holes and cracks where microbes may be concealed (“Fig 1E and 1F”) in the prosthetic valve. Second, electron microscopy showed pathogen-like structures of 500 nm to 2 μm in diameter attached to the surface, clearly suggesting the presence of bacteria. The vast majority seem to be damaged (Fig 1B and 1E, inset). Using high magnification a few bacteria with potential intact morphology were also present (Fig 1C and 1F). Evidence of different bacterial morphologies was also found (Fig 1F).
Ultrastructural transverse cuts of native and prosthetic specimens featured bacterial clusters and scattered localization pattern (Fig 2A and 2B). At high resolution, the majority of bacteria were localized within phagocytic immune cells, identified as monocytes and neutrophil granulocytes by size and the characteristic structural features of their nuclei (Fig 2B, 2F–2H). In addition to cells cluttered with numerous viable bacteria and apparently intact morphology, many cells were detected with plasma membranes partly disrupted, indicating cell death (Fig 2B and 2H). Although released bacteria seemed to be phagocytized by intact monocytes, ultrastructural analysis showed evidence of a process of bacterial escape from phagocytic vacuoles into the cytoplasm (Fig 2B), which may represent a mechanism to circumvent host immune response and enable survival and persistence inside infected cells. Using the most recent 3View-FIB-SEM 3D-reconstructions, intracellular and intramural localization of bacteria was observed in infected valve tissue (Fig 2C–2K). Intracellular and intramural localization of infective bacteria may complicate successful culture-based microbial standard diagnostics. Therefore, we examined whether the application of culture-independent, DNA-based metagenome analysis might be an appropriate method to overcome such difficulties.
Individual genetic fingerprints
The 16S rDNA NGS analysis successfully revealed bacterial pathogens in all patients of the cohort using total DNA and microbial-enriched DNA (Fig 3A–3C). With this technique, we identified a total of 13 bacterial genera from resected patient valves, including 8 genera representing 16 species. In 5 genera (Micrococcus, Paracoccus, Sphingomonas, Serratia, and Pseudomonas), identification by DNA analysis did not succeed at the species level. Furthermore, all patient specimens showed bacterial DNA of the Staphylococcus genus, and in only one patient (patient 5) could the Staphylococcus species not be identified. Aside from 11 well-known IE-related pathogens, our findings revealed several species such as Haloplasma contractile, Atopobium vaginae, Aeribacillus pallidus, Streptococcus pseudopneumoniae, and Burkholderia fungorum that might play a role as IE-related pathogens (Fig 3D). Two species (Haloplasma contractile and Aeribacillus pallidus) have not been previously identified in human infections (S1 Table). The presence that species was verified by specific qPCR analysis (S6 Fig).
In summary, we identified 7 out of 8 cases as being polymicrobial (2–8 species and 2–9 genera per patient), and only one patient showed infection by a single pathogen (Staphylococcus aureus) only (Fig 3B and 3C). By additionally performing specific qPCR analysis of selected bacterial species that we initially found to have high or low abundance by 16S rDNA NGS, we validated our sequencing results and further confirmed the hypothesis of polymicrobial infection (S6 Fig). In contrast, standard culture-based microbial detection revealed only single-pathogen infections in 7 out of 8 cases, with one case being negative (Table 2). Of note, bacterial species identified by culture techniques correlated in 5 out of 6 cases with one of those being identified by DNA analysis.
None of the bacterial species successfully cultivated from patient valves or blood in our cohort showed antibiotic resistance (data not shown). The antibiotic treatment protocol, either as initial empiric therapy or extended medication, covered all identified pathogens in 4 out of 8 cases (Fig 3B and 3C); however, the antibiotics chosen for therapy did not cover the entire bacterial spectra identified by our DNA analysis in 4 out of 8 cases and therefore might not have been sufficient (Fig 3B and 3C).
Discussion
IE remains a major medical issue, with an unchanged incidence and mortality rate over the past 20 years [11, 25]. The mortality rate of 20–30% within the first year of diagnosis and a 5-year mortality rate of 40% are a result of the failure of primary therapy as well as re-infection of prosthetic valves [26, 27]. Despite the myriad of antibiotic regimens currently available (the Federal Institute for Drugs and Medical Devices BfArM states that there were 2,775 approved antibiotics in 2005), apparently adequate treatment does not always result in a cure. It is unclear whether the aforementioned suboptimal outcomes are a result of antibiotic therapy failing to adequately treat the causative organism or whether the causative organism was not accurately identified, thus resulting in inappropriate antibiotic selection.
Interestingly, infections by single bacterial species are described in 99% of all IE cases, based on clinical studies that used standard microbiological approaches [6]. The bacterial species identified were considered to be the causative organism, and therefore antibiotic therapy would be suitably tailored towards it. The origins of pathogens responsible for IE, however, are primarily thought to stem from systemic bacteremia as a result of lesions or surgical interventions of skin or mucosa, leading to barrier leakage and bacterial invasion. One would expect that due to the diversity of bacteria colonizing the skin, gut, and oral mucosa there should be a far higher incidence (than the currently reported 1%) of polymicrobial infections [6]. In the initial phase of infection, blood seems to act as an essential transport vehicle to transfer causative organisms from an unknown infective focus to the heart, causing local valve infection; however, it remains unclear whether the bacterial spectra observed in blood correspond to the spectra of infected valve tissue. If conventional therapy fails and patients demonstrate impaired valve function, surgical intervention with valve replacement is mandatory. This allows accurate tissue diagnosis from the infected valve and further tailoring of antibiotic regimens to prevent prosthetic valve endocarditis by reinfection.
Standard clinical analyses are geared towards the identification of a single pathogen. Major society guidelines recommend blood analysis based on culturing methods to identify the causative organism. In our randomized cohort study of 8 patients with definite acute IE of native valves (3 cases) and biological prostheses (5 cases), we initially analyzed blood profiles. Blood cultures were positive in 7 of our patients and identified as single bacterial infection only (3 species from 2 genera) (Table 2). The success of this method strongly depends on the bacterial ability to grow under artificial culture conditions. Not surprisingly, this is known to fail in 10–48% of patients [6, 12]. The sensitivity is especially limited when antibiotic therapy had been commenced prior to blood drawing and when fastidious or slowly growing microorganisms are involved.
Using standard microbial analysis, only 1 out of 8 valve surface swabs revealed bacterial infestation (Staphylococcus aureus) in our cohort. The low sensitivity of only 12.5% is in line with the results of previous studies that reported sensitivities between 8% and 31% [28, 29]. This is surprising because the valve tissue directly represents the infected focus of the organ (in contrast to blood samples). Our FIB-SEM-based ultrastructure analysis of valve surfaces revealed areas exhibiting smooth structures indicative of native valves without evidence of bacterial colonization or areas containing damaged bacteria or debris and only rarely areas displaying potentially intact bacteria (Fig 1). As a consequence, we conclude that valve-surface swabs may largely fail to take up sufficient bacteria retaining the ability to grow. This finding is further supported by the observation that valve pretreatment with ultrasound raised the sensitivity of culture diagnoses to 50% (3 additional positive cases: Staphylococcus epidermitis, Streptococcus gordonii, Enterococcus faecalis). Moreover, ultrastructural analysis of infected biological prostheses revealed significantly bulky surface structures that might be due to the processing and decellularization of animal pericardial tissue used for prosthesis construction. These cavity-like structures might enhance the potential of bacteria to successfully colonize and allow establishment of a niche ecosystem.
To evaluate the possibility of polymicrobial infections in IE, the present study assessed infective bacterial spectra using a modern genetic approach. Techniques such as 16S rDNA analysis allow culture-independent analysis of bacterial infections, but are not yet part of routine laboratory testing. This method is based on total DNA extraction from clinical samples, universal amplification of bacterial 16S rDNA, sequencing of the resulting PCR amplicons, and alignment of sequences using microbial databases to identify bacterial species. Using 16S rDNA NGS, we identified a total of 13 bacterial genera and 16 species from resected patient valves using (Fig 3). In contrast, culture-based valve and blood diagnosis revealed only 2 bacterial genera and 3 species (Table 2). Aside from the 11 well-known IE-related pathogens, 5 species not previously correlated with IE were identified. These included Haloplasma contractile, Atopobium vaginae, Aeribacillus pallidus, Streptococcus pseudopneumoniae, and Burkholderia fungorum. Information regarding the pathogenicity of these organisms is scarce (S1 Table). Furthermore, mixed infections by Staphylococci with either Streptococci or Enterococci were demonstrated in resected heart valves in 7 of our patients, with a high abundance of specific DNA read counts. Haloplasma, Aeribacillus, Paracoccus, Propionibacterium, Atopobium, Micrococcus, Burkholderia, Serratia, Pseudomonas, and Sphingomonas were also identified at lower abundant read levels. In some cases bacterial DNA enrichment was necessary for successful detection. The high sensitivity of 16S rDNA NGS is an advantage that enables the detection of even small traces of bacterial DNA, independent of the organism’s replication performance. In recent years, studies have reported that bacterial pathogenicity depends on endogenous and exogenous factors and are not restricted to bacterial counts alone [30, 31].
With the use of high-resolution NGS, our results support the hypothesis of a complex microbial diversity in IE, with 7 cases being polymicrobial (2–8 species and 2–9 genera per patient) and only one patient with a single pathogen (Staphylococcus aureus). The sequencing technique chosen is an important factor in detecting the bacterial diversity of a sample. Almost all previous experimental efforts to analyze infected valve tissue from IE by 16S rDNA used capillary Sanger sequencing, and hence these studies were restricted to the detection of only the single most abundant species [32–35]. Consequently, these studies showed no evidence of infective microbial diversity. Unlike capillary sequencing, however, modern sequencing methods allow the analysis of the entire bacterial community within a sample.
The results of 16S rDNA NGS analysis depend to a varying degree on the use of microbial DNA enrichment procedures, selection of the 16S rDNA region to be amplified, and the number of measurement repetitions. Our estimated recovery rates varied from approximately 80% to 60% in a linear correlation with the cut-off levels of minimum proportion of species-specific sequenced reads from 2% to 0.1%, applied respectively. Our data suggest that the variation in results observed is mainly based on the cut-off levels applied. This means the likelihood of reproducible discovery is much higher for bacterial species present in high abundance (S5 Fig).
Theoretically, in 16S rDNA-based metagenome analysis, PCR amplification of the 16S rDNA target region from multiple bacterial species should take place in parallel under identical conditions within a single assay. But in fact, highly abundant DNA targets compete and therefore suppress the amplification of targets with low abundance. In other words, the spectra of the bacterial species observed tend to be underestimated rather than overestimated. For species with low abundance, the use of a specific qPCR analysis would appear to have a higher sensitivity (S6 Fig). From a clinical standpoint, we propose that species identified with low abundance should be validated by specific qPCR analysis.
Culture-based microbiology was unable to detect pathogens in 4 out of 8 infected valves, whereas, 16S rDNA NGS revealed bacteria in all cases (Table 2 and Fig 3). In comparison with culture-based microbial analysis, the main weakness of the sequencing approaches is the inability to distinguish between living or dead bacteria and the inability to test for antibiotic resistance. Surprisingly, none of the bacterial species successfully cultivated from patient valves or blood in our cohort revealed any relevant antibiotic resistance (data not shown). The antibiotics chosen for therapy, however, did not cover the bacterial spectra identified by our metagenome analysis in 4 out of 8 cases; of these 4 patients, 2 died postoperatively. The clinical condition of the patients made surgical intervention with valve replacement mandatory.
An additional challenge for standard microbial analysis is the detection, identification, and culturing of intracellularly occurring pathogens [36]. In particular, Staphylococcus aureus, as identified in 7 out of 8 cases of our cohort, is now recognized as a facultative intracellular pathogen that is able to invade, survive, and replicate intracellularly, e.g. in endothelial and epithelial cells. Using 3D imaging, our data show for the first time proof of intracellular and intramural localization of pathogens in both native and prosthetic heart valves by applying sophisticated FIB-SEM. This microbial strategy may represent an effective mechanism to evade host immune defense and may contribute to the persistence of endocarditis induced by S. aureus [37]. Even for immune-competent professional phagocytes like neutrophil granulocytes and monocytes, intracellular colonization has been demonstrated [37]. This observation was confirmed by 3D reconstruction using our FIB-SEM data (Fig 2, S1–S3 Movies). In addition to Staphylococci, Streptococci showed evidence of intracellular cytosolic survival circumventing host immune mechanisms. Intracellular survival of Streptococci in polymorphonuclear neutrophils has also been reported in experiments in mice, leading to increased bacterial virulence [38].
The occult localization of certain bacterial species strongly suggests that the standard microbiological diagnosis (e.g. from valve swabs) is not sensitive enough. This creates challenges for a targeted antibiotic therapy. Furthermore, many facultative intracellular bacteria are characterized by impaired growth and reduced metabolism [36]. The effectiveness of antibacterial agents, however, strongly depends on bacterial growth or cellular metabolic activity, with only a few exceptions such as daptomycin and gramicidin [39]. Based on our findings, antibiotic agents must first penetrate the valve surface, then disseminate into tissue, and finally enter both the intact membranes of host cells and bacterial cell walls to be effective. Thus, pharmacokinetic studies should investigate whether antibiotics administered orally or intravenously are properly dosed to result in an effective intracellular cytosolic level.
In conclusion, the high frequency of polymicrobial infections, pathogen diversity, and intracellular persistence of common IE-causing bacteria may provide clues to explain the persistent, devastating mortality rate observed in IE. Improved bacterial diagnosis by 16S rDNA NGS methods resulting in the ability to tailor antibiotic therapy may lead to improved outcomes. Potential caveats, however, include the inability to distinguish between living and dead organisms and the unknown immunogenicity and pathogenicity of species detected in low abundance; these drawbacks remain to be resolved.
Supporting information
Acknowledgments
The authors greatly acknowledge Mrs. Annett Weimann for the excellent technical assistance with electron microscopic sample preparation.
Data Availability
Our sequencing dataset was deposited at European Nucleotide Archive (ENA) repository (http://www.ebi.ac.uk/ena; study accession number PRJEB19021; study unique name ena-STUDY-Fraunhofer IZI-16-01-2017-17:05:23:619-207).
Funding Statement
The study of electron microscopy methodology was provided by Carl Zeiss Microscopy GmbH. The support included one person [RN], who was responsible for electron microscopy. There is no financial relationship between all other authors and Carl Zeiss Microscopy GmbH, except to author [RN]. RN is employed by the by Carl Zeiss Microscopy GmbH. The specific roles of this author is articulated in the 'author contributions' section.
References
- 1.Correa de Sa DD, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD, et al. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clinic proceedings. 2010;85(5):422–6. 10.4065/mcp.2009.0585 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. Journal of the American College of Cardiology. 2012;59(22):1968–76. [DOI] [PubMed] [Google Scholar]
- 3.Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC infectious diseases. 2011;11:48 10.1186/1471-2334-11-48 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999–2008. Archives of internal medicine. 2012;172(4):363–5. 10.1001/archinternmed.2011.1027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hoen B, Duval X. Clinical practice. Infective endocarditis. The New England journal of medicine. 2013;368(15):1425–33. 10.1056/NEJMcp1206782 [DOI] [PubMed] [Google Scholar]
- 6.Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr., Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of internal medicine. 2009;169(5):463–73. 10.1001/archinternmed.2008.603 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012;54(9):1230–9. [DOI] [PubMed] [Google Scholar]
- 8.Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. European heart journal. 2010;31(15):1890–7. 10.1093/eurheartj/ehq110 [DOI] [PubMed] [Google Scholar]
- 9.Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. European heart journal. 2009;30(19):2369–413. [DOI] [PubMed] [Google Scholar]
- 10.Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2006;25(3):181–5. [DOI] [PubMed] [Google Scholar]
- 11.Moter A, Musci M, Schmiedel D. Molecular methods for diagnosis of infective endocarditis. Current infectious disease reports. 2010;12(4):244–52. 10.1007/s11908-010-0111-6 [DOI] [PubMed] [Google Scholar]
- 12.Tariq M, Alam M, Munir G, Khan MA, Smego RA Jr. Infective endocarditis: a five-year experience at a tertiary care hospital in Pakistan. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2004;8(3):163–70. [DOI] [PubMed] [Google Scholar]
- 13.Abramczuk E, Stepinska J, Hryniewiecki T. Twenty-Year Experience in the Diagnosis and Treatment of Infective Endocarditis. PloS one. 2015;10(7):e0134021 10.1371/journal.pone.0134021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Wimmer MD, Friedrich MJ, Randau TM, Ploeger MM, Schmolders J, Strauss AA, et al. Polymicrobial infections reduce the cure rate in prosthetic joint infections: outcome analysis with two-stage exchange and follow-up >/ = two years. International orthopaedics. 2015. [DOI] [PubMed] [Google Scholar]
- 15.Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14. 10.1038/nature11234 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–20. 10.1093/bioinformatics/btu170 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC bioinformatics. 2009;10:421 10.1186/1471-2105-10-421 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Huson DH, Mitra S. Introduction to the analysis of environmental sequences: metagenomics with MEGAN. Methods in molecular biology. 2012;856:415–29. 10.1007/978-1-61779-585-5_17 [DOI] [PubMed] [Google Scholar]
- 19.Martineau F, Picard FJ, Roy PH, Ouellette M, Bergeron MG. Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus. Journal of clinical microbiology. 1998;36(3):618–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Layton BA, Walters SP, Lam LH, Boehm AB. Enterococcus species distribution among human and animal hosts using multiplex PCR. Journal of applied microbiology. 2010;109(2):539–47. 10.1111/j.1365-2672.2010.04675.x [DOI] [PubMed] [Google Scholar]
- 21.Park SN, Lim YK, Kook JK. Development of species-specific quantitative real-time PCR primers for detecting anginosus group streptococci based on the rpoB. Archives of microbiology. 2014;196(9):661–6. 10.1007/s00203-014-1007-x [DOI] [PubMed] [Google Scholar]
- 22.Chan CH, Stead DE, Coutts RH. Development of a species-specific recA-based PCR test for Burkholderia fungorum. FEMS microbiology letters. 2003;224(1):133–8. [DOI] [PubMed] [Google Scholar]
- 23.Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC bioinformatics. 2012;13:134 10.1186/1471-2105-13-134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Deerinck TJ BE, Thor A, Mark H, Ellisman MH. NCMIR METHODS FOR 3D EM: A NEW PROTOCOL FOR PREPARATION OF BIOLOGICAL SPECIMENS FOR SERIAL BLOCKFACE SCANNING ELECTRON MICROSCOPY: Center for Research in Biological Systems and the National Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, CA, USA; 2013 [cited 2013 09–11]. Protocol]. https://www.ncmir.ucsd.edu/sbem-protocol/.
- 25.Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363(9403):139–49. 10.1016/S0140-6736(03)15266-X [DOI] [PubMed] [Google Scholar]
- 26.Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, et al. Changing patient characteristics and the effect on mortality in endocarditis. Archives of internal medicine. 2002;162(1):90–4. [DOI] [PubMed] [Google Scholar]
- 27.Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care—associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Annals of internal medicine. 2002;137(10):791–7. [DOI] [PubMed] [Google Scholar]
- 28.Greub G, Lepidi H, Rovery C, Casalta JP, Habib G, Collard F, et al. Diagnosis of infectious endocarditis in patients undergoing valve surgery. The American journal of medicine. 2005;118(3):230–8. 10.1016/j.amjmed.2004.12.014 [DOI] [PubMed] [Google Scholar]
- 29.Breitkopf C, Hammel D, Scheld HH, Peters G, Becker K. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation. 2005;111(11):1415–21. 10.1161/01.CIR.0000158481.07569.8D [DOI] [PubMed] [Google Scholar]
- 30.do Vale A, Cabanes D, Sousa S. Bacterial Toxins as Pathogen Weapons Against Phagocytes. Frontiers in microbiology. 2016;7:42 10.3389/fmicb.2016.00042 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Vorland LH. [What makes bacteria pathogenic?]. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke. 2001;121(26):3083–9. [PubMed] [Google Scholar]
- 32.Dreier J, Szabados F, von Herbay A, Kroger T, Kleesiek K. Tropheryma whipplei Infection of an acellular porcine heart valve bioprosthesis in a patient who did not have intestinal Whipple's disease. Journal of clinical microbiology. 2004;42(10):4487–93. 10.1128/JCM.42.10.4487-4493.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Duffett S, Missaghi B, Daley P. Culture-negative endocarditis diagnosed using 16S DNA polymerase chain reaction. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale / AMMI Canada. 2012;23(4):216–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Pada S, Lye DC, Leo YS, Barkham T. Utility of 16S ribosomal DNA sequencing in the diagnosis of Staphylococcus lugdunensis native valve infective endocarditis: case report and literature review. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2009;13(6):e511–3. [DOI] [PubMed] [Google Scholar]
- 35.Vollmer T, Piper C, Horstkotte D, Korfer R, Kleesiek K, Dreier J. 23S rDNA real-time polymerase chain reaction of heart valves: a decisive tool in the diagnosis of infective endocarditis. European heart journal. 2010;31(9):1105–13. 10.1093/eurheartj/ehp600 [DOI] [PubMed] [Google Scholar]
- 36.Kahl BC. Small colony variants (SCVs) of Staphylococcus aureus—a bacterial survival strategy. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2014;21:515–22. 10.1016/j.meegid.2013.05.016 [DOI] [PubMed] [Google Scholar]
- 37.Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP. Survival of Staphylococcus aureus inside neutrophils contributes to infection. Journal of immunology. 2000;164(7):3713–22. [DOI] [PubMed] [Google Scholar]
- 38.Medina E, Rohde M, Chhatwal GS. Intracellular survival of Streptococcus pyogenes in polymorphonuclear cells results in increased bacterial virulence. Infection and immunity. 2003;71(9):5376–80. 10.1128/IAI.71.9.5376-5380.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Mascio CT, Alder JD, Silverman JA. Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrobial agents and chemotherapy. 2007;51(12):4255–60. 10.1128/AAC.00824-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Our sequencing dataset was deposited at European Nucleotide Archive (ENA) repository (http://www.ebi.ac.uk/ena; study accession number PRJEB19021; study unique name ena-STUDY-Fraunhofer IZI-16-01-2017-17:05:23:619-207).